Zusammenfassung
Neoplasmen der Prostata, der Blase und der Nieren zählen zu den häufigsten Tumoren, die den menschlichen Körper betreffen. Sie sind oft symptomarm, so daß die Diagnose erst zu einem sehr späten Zeitpunkt möglich ist. Hodentumoren sind sehr bösartig und treten vorwiegend bei jungen Männern auf. Neoplasmen der Harnleiter, der Harnröhre, des Penis, des Skrotums, des Nebenhodens und der Samenblasen sind selten.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Gutartige Tumoren des Nierenparenchyms
Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Fascicle 12 of: Atlas of Tumor Pathology, 2nd series. Armed Forces Institute of Pathology, 1975
Bissada NK et al: Tuberous sclerosis complex and renal angiomyolipoma. Urology 1975; 6:105
Dennis RL et al: Juxtaglomerular cell tumor of the kidney. J Urol 1985; 134:334
Dunnick NR et al: The radiology of juxtaglomerular tumors. Radiology 1983; 147:321
Farrow GM et al: Renal angiomyolipoma: A clinical pathological study of 32 patients. Cancer 1968; 22:564
Jardin A et al: Diagnosis and treatment of renal angiomyolipoma (based on 15 cases): Arguments in favor of conservative surgery (based 8 cases). Eur Urol 1980; 6:69
Oesterling JE et al: Management of renal angiomyolipoma. J Urol 1986; 135:1121
Shapiro RA et al: Renal tumors associated with tuberous sclerosis: The case for aggressive surgical management. J Urol 1984; 132:1170
Squires JP et al: Juxtaglomerular cell tumor of the kidney. Cancer 1984; 53:516
Zerhouni EA et al: Management of bleeding renal angio-myolipomas by transcatheter embolization following CT diagnosis. Urol Radiol 1984; 6:205.
Adenokarzinom der Niere
Almgard LE et al: Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation. Br J Urol 1973; 45:474
Altaffer LF III, Chenault OEW Jr, Paraneoplastic endo-crinopathies associated with renal tumors. J Urol 1979; 122:573
Babaian RJ, Swanson DA: Serum haptoglobin: A nonspecific tumor marker for renal cell carcinoma. South Med J 1982; 75:145
Balfe DM et al: Evaluation of renal masses considered in-determinant on computed tomography. Radiology 1982; 142:421
Bander NH: Comparison of antigen expression of human renal cancers in vivo and in vitro. Cancer 1984; 53:1235
Barnes CA, Beckman EN: Renal oncocytoma and its congeners. Am J Clin Pathol 1983; 79–312
Beahrs OH, Myers MH (editors): Manual for Staging Cancer, 2nd ed. Lippincott, 1983
Bell ET: Renal Diseases, 2nd ed. Lea & Febiger, 1950
Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975
Bennington JL, Kradjian RM: Renal Carcinoma. Saunders, 1967
Bennington JL, Laubscher FA: Epidemiologic studies on carcinoma of the kidney. 1. Association of renal adenocarcinoma with smoking. Cancer 1968; 21:1069
Bloom HJG: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973; 32:1066
Bowers TA et al: Bone metastases from renal carcinoma: The preoperative use of transcatheter arterial occlusion. J Bone Joint Surg (Am) 1982; 64:749
Boxer RJ et al: Renal carcinoma: Computer analysis of 96 patients treated by nephrectomy. J Urol 1979; 122:598
Bracken RB et al: Secondary renal neoplasms: An autopsy study. South Med J 1979; 72:806
Brereton HD et al: Indomethacin-responsive hypercalcemia in a patient with a renal cell carcinoma. N Engl J Med 1974; 291:83
Bush WH Jr, Burnett LL, Gibbons RP: Needle tract seeding of renal cell carcinoma. AJR 1977; 129:725
Cherrie RJ et al: Prognostic implications of vena caval extension of renal cell carcinoma. J Urol 1982; 128:910
Cho C, Friedland GW, Swenson RS: Acquired renal cystic disease and renal neoplasms in hemodialysis patients. Urol Radiol 1984; 6:153
Chuang VP, Wallace S, Swanson DA: Technique and complications of renal carcinoma infarction. Urol Radiol 1981; 2:223
Chuang VP et al: Arterial occlusion in the management of pain from metastatic renal carcinoma. Radiology 1979; 133:611
Cockett ATK: Lymphatic network of the kidney. 1. Anatomic and physiologic considerations. Urology 1977; 9:125
Cohen AJ et al: Hereditary renal cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301:592
Cronan JJ, Zeman RK, Rosenfield AT: Comparison of computed tomography, ultrasound, and angiography in staging renal cell carcinoma. J Urol 1982; 127:712
Daniel WW Jr et al: Calcified renal masses: A review of ten years’ experience at the Mayo Clinic. Radiology 1972; 103:503
deKernion JB: Lymphadenectomy for renal cell carcinoma. Urol Clin North Am 1980; 7:697
deKernion JB, Berry D: The diagnosis and treatment of renal cell carcinoma. Cancer 1980; 44 (Suppl):1947
deKernion JB, Ramming KP: The therapy of renal adenocarcinoma with immune RNA. Invest Urol 1980; 17:378
deKernion JB et al: The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 1983; 130:1063
Engelmann U et al: Digital subtraction angiography in staging renal cell carcinoma: Comparison with computerized tomography and histopathology. J Urol 1984; 132:1093
Figlin RA et al: Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: A phase 1–11 trial. Cancer Treat Rep 1985; 69:263
Finstad CL et al: Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci USA 1985; 85:2955
Flocks RH, Kadesky MC: Malignant neoplasms of the kidney: An analysis of 353 patients followed 5 years or more. J Urol 1958; 79:196
Fossa SD et al: Recombinant interferon a-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 1986; 57:1700
Freed SZ, Halperin JP, Gordon M: Idiopathic regression of metastases from renal cell carcinoma. J Urol 1977; 118:538
Gibbons RP et al: Manifestations of renal cell carcinoma. Urology 1976; 8:201
Goldberg MF et al: Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemia. Am J Med 1964; 36:805
Golimbu M et al: Renal cell carcinoma: Survival and prognostic factors. Urology 1986; 27:291
Harris DT: Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol 1983; 10:422
Hellekant C, Nyman CL: Routine celiac arteriography in patients with renal cell carcinoma. J Urol 1979; 122:17
Heney NM, Nocks BN: The influence of perinephric fat involvement on survival in patients with renal cell carcinoma extending into the inferior vena cava. J Urol 1982; 128:18
Hoehn W, Hermanek P: Invasion of veins in renal cell carcinoma: Frequency, correlation and prognosis. Eur Urol 1983; 9:276
Holland JM: Cancer of the kidney: Natural history and staging. Cancer 1973; 32:1030
Hop WCJ, van der Werf-Messing BHP: Prognostic indexes for renal cell carcinoma. Eur J Cancer 1980; 16:833
Horn L, Horn HL: An immunological approach to the therapy of cancer. Lancet 1971; 2:466
Horton WA, Wong V, Eldridge R: Von Hippel-Lindau disease: Clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 1976; 136:769
Hricak H et al: Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms. Radiology 1985; 154:709
Hrushesky WJ, Murphy GP: Current status of the therapy of advanced renal carcinoma. J Surg Oncol 1977; 9:277
Hughson MD, Buchwald D, Fox M: Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986; 110:592
Hulten L et al: Occurrence and localization in lymph node metastases in renal carcinoma. Scand J Urol Nephrol 1969; 3:129
Jacobs SC, Berg SI, Lawson RK: Synchronous bilateral renal cell carcinoma: Surgical excision. Cancer 1980; 46:2341
Johnson DE, von Eschenbach AC, Sternberg J: Bilateral renal cell carcinoma. J Urol 1978; 119:23
Kato T et al: Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C.J Urol 1981; 125:19
Kearney GP et al: Results of inferior vena cava resection for renal cell carcinoma. J Urol 1981; 125:769
Kirkman H: Estrogen-induced tumors of the kidney. Natl Cancer Inst Monogr 1959; 1:1
Klein MJ, Valensi QJ: Proximal tubular adenocarcinoma of the kidney with so-called oncocytic features: A clinical pathologic study of 13 cases of a rarely reported neoplasm. Cancer 1976; 38:906
Krane RJ et al: Removal of renal cell carcinoma extending into the right atrium using cardiopulmonary bypass, profound hypothermia and circulatory arrest. J Urol 1984; 131:945
Krown SE et al: Treatment of advanced renal cell carcinoma (RCC) with recombinant leukocyte A interferon (rIFN-A). (Abstract) Am Soc Clin Oncol 1983; 2:58
Lang ED: Arteriography in the diagnosis and staging of hypernephromas. Cancer 1973; 32:1043
Lang EK: Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma. Cancer 1984; 54:2205
Lang EK, Sullivan J, deKernion JB: Work in progress: Transcatheter embolization of renal cell carcinoma with radioactive infarct particles. Radiology 1983; 147:413
Levine E et al: CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients. AJR 1984; 142:125
Lieber MM, Tornera KM, Farrow GM: Renal oncocytoma. J Urol 1981; 125:481
Lieber MM et al: Renal adenocarcinoma in young adults: Survival and variables affecting prognosis. J Urol 1981; 125:164
Ljungberg B et al: Prognostic significance of DNA content in renal cell carcinoma. J Urol 1986; 135:422
Lytton B, Rosof B, Evans JS: Parathyroid hormone-like activity in a renal carcinoma producing hypercalcemia. J Urol 1965; 93:127
Maldazys JD, deKernion JB: Prognostic factors in metastatic renal carcinoma. J Urol 1986; 136:376
Malek RS, Utz DC, Culp OS: Hypernephroma in the solitary kidney: Experience with 20 cases and review of the literature. J Urol 1976; 116:553
Marshall FF, Reitz BA, Diamond DA: A new technique for management of renal cell carcinoma involving the right atrium: Hypothermia and cardiac arrest. J Urol 1984; 131:103
McCune CS, Schapira DV, Henshaw EC: Specific immunotherapy of advanced renal carcinoma: Evidence for the polyclonality of metastases. Cancer 1981; 47:1984
McDonald JR, Priestly JT: Malignant tumors of the kidney: Surgical and prognostic significance of tumor thrombosis of the renal vein. Surg Gynecol Obstet 1943; 77:295
McDonald MW: Current therapy for renal carcinoma. J Urol 1982; 127:211
McNichols DW, Segura JW, DeWeerd JH: Renal cell carcinoma: Long-term survival and late recurrence. J Urol 1981; 126:17
Morales A et al: Cytoreductive surgery and systemic bacille Calmette-Guérin therapy in metastatic renal cancer: A phase II trial. J Urol 1982; 127–230
Morlock CG, Horton BT: Variations in systolic blood pressure in renal tumors: A study of 491 cases. Am J Med Sci 1936; 191:647
Murphy JB, Marshall FF: Renal cyst versus tumor: A continuing dilemma. J Urol 1980; 123:566
Neidhart JA: Interferon therapy for the treatment of renal cancer. Cancer 1986; 57 (8 Suppl): 1696
Neidhart JA et al: Active specific immunotherapy of stage IV renal carcinoma with aggregated tumor antigen adjuvant. Cancer 1980; 46:1128
Neidhart JA et al: Interferon-alpha therapy of renal cancer. Cancer Res 1984; 44:4140
Novick AC et al: Partial nephrectomy in the treatment of renal adenocarcinoma. J Urol 1977; 118:932
Novick AC et al: Surgical enucleation for renal cell carcinoma. J Urol 1986; 135:235
Oberling C, Riviere M, Haguenau F: Ultrastructure of the clear cells in renal cell carcinoma and its importance for the demonstration of their renal origin. Nature 1960; 186:402
O’Dea MJ et al: The treatment of renal cell carcinoma with solitary metastasis. J Urol 1978; 120:540
Otto U et al: Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol 1984; 132:237
Parienty RA et al: Local recurrence after nephrectomy for primary renal cancer: Computerized tomography recognition. J Urol 1984; 132:246
Petersson S et al: Diagnostic value of lipid content in cyst fluid. Pages 433–434 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors) A. R. Liss, 1982
Petkovic S: Le stade anatomique dans l’appréciation du prognostique des tumeurs rénales. Urologia 1956; 23:125
Petkovic S: The value of tumor tissue penetration into the renal veins and lymph nodes as an anatomical classification in kidney tumor prognostic parameters. Eur Urol 1980; 6:289
Pritchett TR, Lieskovsky G, Skinner DG: Extension of renal cell carcinoma into vena cava: Clinical review and surgical approach. J Urol 1986; 135:460
Quesada JR, Swanson DA, Guttermann JU: Phase II study of interferon alpha in metastatic renal-cell carcinoma: A progress report. J Clin Oncol 1985; 3:1086
Quesada JR et al: Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 1985; 3:1522
Riches EW, Griffiths IH, Thackray AC: New growths of the kidney and ureter. Br J Urol 1951; 23:297
Richie JP et al: Computerized tomography scan for diagnosis and staging of renal cell carcinoma. J Urol 1983; 129:1114
Richie JP et al: Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid. J Urol 1984; 131:236
Robey EL, Schellhammer PF: Adrenal gland and renal cell carcinoma: Is ipsilateral adrenalectomy a necessary component of radical nephrectomy? J Urol 1986; 135:453
Robson CJ, Churchill B, Anderson W: Radical nephrectomy for renal cell carcinoma. J Urol 1969; 101:297
Rosenberg SA et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485
Rouvière H: Anatomy of the Human Lymphatic System. Tobias MJ (translator) Edwards Brothers, 1938
Schaner EG et al: Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: A prospective radiologic-pathologic study. AJR 1978; 131:51
Spiessl B, Scheibe O, Wagner G (editors) TNM-Atlas: Illustrated Guide to the Classification of Malignant Tumors. Springer-Verlag, 1982
Stauffer MH: Nephrogenic hepatosplenomegaly. Gastroenterology 1961; 40:694
Sufrin G et al: Hormones in renal cancer. J Urol 1977; 117:433
Swanson DA: Management of stage IV renal cancer. In: Principles and Management of Urologic Cancer, 2nd ed. Javadpour N (editor). Williams & Wilkins, 1983
Swanson DA: Transabdominal radical nephrectomy. Pages 321–335 in: Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Johnson DE, Boileau MA (editors). Grune & Stratton, 1982
Swanson DA, Bernardino ME: “Silent” osseous metastases in renal cell carcinoma: Value of CT. Urology 1982; 20:208
Swanson DA, Liles A: Bladder metastasis: A rare cause of hematuria in renal carcinoma. J Surg Oncol 1982; 20:80
Swanson DA et al: Angioinfarction and nephrectomy for metastatic renal cell carcinoma: An update. J Urol 1983; 130:449
Swanson DA et al: Osseous metastases secondary to renal cell carcinoma. Urology 1981; 18:556
Tallberg T et al: Active specific immunotherapy with supportive measures in the treatment of palliatively ne-phrectomized, renal adenocarcinoma patients: A thirteen-year follow-up study. Eur Urol 1985; 11:233
Topley M, Novick AC, Montie JE: Long-term results following partial nephrectomy for localized renal adenocarcinoma. J Urol 1984; 131:1050
van der Werf-Messing B, van der Heul RO, Ledeboer RC: Renal cell carcinoma trial. Cancer Clin Trials 1978; 1:13
Vickers M Jr: Serum haptoglobins: A preoperative detector of metastatic renal carcinoma. J Urol 1974; 112:310
Wallace AC, Nairn RC: Renal tubular antigens in kidney tumors. Cancer 1972; 29:977
Warren MM, Kelalis PT, Utz DL: The changing concept of hypernephroma. J Urol 1970; 104:376
Wehle MJ, Grabstald H: Contraindications to needle aspiration of solid renal mass: Tumor dissemination by renal needle aspiration. J Urol 1986; 136:446
Williams RD, Hricak H: Magnetic resonance imaging in urology. J Urol 1984; 132:641
Wynder EL, Mabuchi K, Whitmore WF Jr: Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 1974:53:16
Zabbo A et al: Digital subtraction angiography for evaluating patients with renal carcinoma. J Urol 1985; 134:252
Zincke H et al: Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantation. Mayo Clin Proc 1985; 60:651
Wilms-Tumor
Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms’ tumor. Cancer 1978; 41:1937
Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975
Bishop HC et al: Survival in bilateral Wilms’ tumor: Review of 30 National Wilms’ Tumor Study cases. J Pediatr Surg 1977; 12:631
Bolande RP, Brough AJ, Izant RJ Jr: Congenital meso-blastic nephroma of infancy: A report of 8 cases and the relationship to Wilms’ tumor. Pediatrics 1967:40:272
Bove KE, McAdams AJ: The nephroblastomatosis complex and its relationship to Wilms’ tumor: A clinical pathologic treatise. Perspect Pediatr Pathol 1976; 3:185
Bracken RB et al: Preoperative chemotherapy for Wilms’ tumor. Urology 1982; 19:55
Breslow NE, Beckwith JB: Epidemiological features of Wilms’ tumor: Results of the National Wilms’ Tumor Study. J Natl Cancer Inst 1982; 68:429
Breslow NE et al: Prognosis for Wilms’ tumor patients with nonmetastatic disease of diagnosis: Results of the second National Wilms’ Tumor Study. J Clin Oncol 1985; 3:521
Clouse JW et al: The changing management of Wilms’ tumor over a 30-year period: 1949–1978. Cancer 1985; 56:1484
D’Angio GJ et al: The treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Cancer 1976; 38:633
D’Angio GJ et al: The treatment of Wilms’ tumor: Results of the Second National Wilms’ Tumor Study. Cancer 1981; 47:2302
D’Angio GJ et al: Wilms’ tumor: Genetic aspects and etiology: A report of the National Wilms’ Tumor Study (NWTS) Committee of the NWTS Group. Pages 43–57 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A.R.Liss, 1982
D’Angio GJ et al: Wilms’ tumor: An update. Cancer 1980; 45:1791
deKraker J et al: Preoperative chemotherapy in Wilms’ tumour: Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). Pages 131–194 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A. R. Liss, 1982
Farewell VT et al: Retrospective validation of a new staging system for Wilms’ tumor. Cancer Clin Trials 1981; 4:167
Hartman DS et al: Mesoblastic nephroma: Radiologic, pathologic correlation of 20 cases. AJR 1981; 136:69
Jaffe N et al: Childhood urologic cancer therapy related sequelae and their impact on management. Cancer 1980; 45:1815
Kay R, Tank E: Current management of bilateral Wilms tumor. J Urol 1986; 135:983
Knudson Ag Jr, Strong LC: Mutation in cancer. A model for Wilms’ tumor of the kidney. J Natl Cancer Inst 1972; 48:313
Leape LL: Diagnosis and management of Wilms’ tumor and neuroblastomas. Pages 179–199 in: Genitourinary Cancer. Skinner DG, deKernion JB (editors). Saunders, 1978
Leape LL, Breslow NE, Bishop HC: The surgical treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Ann Surg 1978; 187:351
Lemierle J: The treatment of Wilms’ tumor in 1982: The status of the art. Pages 167–171 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A.R.Liss, 1982
Lemerle J et al: Effectiveness of preoperative chemotherapy in Wilms’ tumor: Results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1983; 1:604
Lemerle J et al: Wilms’ tumor: Natural history and prognostic factors: A retrospective study of 248 cases treated at the Institute Gustave-Roussy 1952–1967. Cancer 1976; 36:2557
Pendergrass TW: Congenital anomalies in children with Wilms’ tumor. Cancer 1976; 37:403
Rous SN et al: Nodular renal blastema, nephroblastomato-sis, and Wilms’ tumor: Different points on the same disease spectrum. Urology 1976; 8:599
Yunis JJ, Ramsay NKC: Familial occurrence of the aniridia-Wilms’ tumor syndrome with deletion 11. J Pediatr 1980; 96:1027
Nierensarkom
Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975
Farrow GM et al: Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Cancer 1968; 22:545
Srinivas V et al: Sarcomas of the kidney. J Urol 1984; 132:13.
Nierenbeckentumoren
Almgard LE et al: Thorotrast-induced renal tumors after retrograde pyelograms. Eur Urol 1977; 3:69
Batata MA et al: Primary carcinoma of the ureter: A prognostic study. Cancer 1975; 35:1626
Boijsen E, Falin J: Angiography in carcinoma of the renal pelvis. Acta Radiol [Diagn] (Stockh) 1961; 56:81
Brookland RK, Richter MP: The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 1985; 133:952
Grabstald H, Whitmore WF, Melamed MR: Renal pelvic tumors. JAMA 1971; 281:845
Johansson S, Wahlqvist L: A prognostic study of urothelial renal pelvic tumors: Comparison between the prognosis of patients treated with intrafascial nephrectomy and perifascial nephroureterectomy. Cancer 1979; 43:2525
Melicow MM: Tumor of the urinary drainage tract: Urothelial tumors. J Urol 1945; 54:186
Mitty HA, Baron MG, Fuler M: Infiltrating carcinoma of the renal pelvis: Angiographic features. Radiology 1969; 92:994
Toppercer A: Fibroepithelial tumor of the renal pelvis. Can J Surg 1980; 23:269.
Harnleitertumoren
Arger PH et al: Ultrasonic assessment of renal transitional cell carcinoma: Preliminary report. AJR 1979; 132:407
Babaian RJ, Johnson DE, Chan RC: Combination nephroureterectomy and postoperative radiotherapy for infiltrative ureteral carcinomas. Int J Radiat Oncol Biol Phys 1980; 6:1229
Batata MA et al: Primary carcinoma of the ureter: A prognostic study. Cancer 1975; 35:1626
Gill WB, Lu CT, Bibbo M: Retrograde ureteral brushing. Urology 1978; 12:279
Huffman JL et al: Endoscopic diagnosis and treatment of upper-tract urothelial tumors: A preliminary report. Cancer 1985; 55:1422
Johnson DE, Babaian RJ: Conservative surgical management for noninvasive distal ureteral carcinoma. Urology 1979; 13:365
Kiriyama T, Hironaka H, Fukuda K: Six years of experience with retrograde biopsy of intraureteral carcinoma using the Dormia stone basket. J Urol 1976; 116:308
Schmauz R, Cole P: Epidemiology of cancer of the renal pelvis and ureter. J Natl Cancer Inst 1974; 52:1431.
Blasentumoren
Anderstrom C et al: A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 1983; 9:142
Babaian RJ et al: Metastases from transitional cell carcinoma of urinary bladder. Urology 1980; 16:142
Benson RC Jr: Treatment of diffuse transitional cell carcinoma in situy by whole bladder hematoporphyrin derivative Photodynamic therapy. J Urol 1985; 134:675
Boileau MA et al: Bladder carcinoma: Results with preoperative radiotherapy and radical cystectomy. Urology 1980; 16:569
Botto H et al: Treatment of malignant bladder tumors by iridium-192 wiring. Urology 1980; 16:467
Bracken RB, McDonald MW, Johnson DE: Cystectomy for superficial bladder tumors. Urology 1981; 18:459
Brosman SA: The use of bacillus Calmette-Quérin in the therapy of bladder carcinoma in situ. J Urol 1985; 134:36
Burnand KG et al: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 1976; 48:55
Byar D, Blackard C: Veterans Administration Cooperative Urological Research Group: Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 1977; 10:556
Chan RC, Bracken RB, Johnson DE: Single dose whole pelvis megavoltage irradiation for palliative control of hematuria or ureteral obstruction. J Urol 1979; 122:750
Cole P, Hoover R, Fridell GH: Occupation and cancer of the lower urinary tract. Cancer 1972; 29:1250
Collan Y, Makinen J, Heikkinen A: Histological grading of transitional cell tumours of the bladder: Value of histological grading (WHO) in prognosis. Eur Urol 1979; 5:311
Connolly JG et al: Relationship between the use of artificial sweeteners and bladder cancer. (Correspondence.) Can Med Assoc J 1978; 119:408
Cummings KB et al: Segmental resection in the management of bladder carcinoma. J Urol 1978; 119:56
Dan RO: Grading of epithelial tumors of urinary bladder. J Urol 1936; 36:651
de Kernion JB et al: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Quérin. J Urol 1985; 133:598
Dretler SP, Ragsdale BD, Leadbetter WF: The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol 1973; 109:414
England HR et al: Evaluation of Helmstein’s distention method for carcinoma of the bladder. Br J Urol 1973; 45:593
Falor WH, Ward RM: Prognosis in early carcinoma of the bladder based on chromosomal analysis. J Urol 1978; 119:44
Falor WH, Ward RM: Prognosis in well-differentiated noninvasive carcinoma of the bladder based on chromosomal analysis. Surg Gynecol Obstet 1977; 144:515
Fisher MR, Hricak H, Tanagho EA: Urinary bladder MR imaging. 2. Neoplasm. Radiology 1985; 157–471
Hall RR: Intravesical hyperthermia for transitional cell carcinoma of the bladder. Pages 267–270 in: Bladder Tumors and Other Topics in Urological Oncology. Vol 1. Pavone-Macaluso M, Smith PH, Edsmyr F (editors). Plenum Press, 1980
Glashan RW: Treatment of carcinoma in situ of the bladder with doxorubicin (Adriamycin). Cancer Chemother Pharmacol 1983; II (Suppl): S35
Hatch TR, Barry JM: Value of excretory urography in staging bladder cancer. J Urol 1986; 135:49
Heney NM: First-line chemotherapy of superficial bladder cancer: Mitomycin vs thiotepa. Urology 1985; 26 (Suppl): 27
Herr HW et al: Long-term effect of intravesical bacillus Calmette-Guérin on flat carcinoma in situ of bladder. J Urol 1986; 135:265
Hewitt CB, Babiszewski JF, Antunez AR: Update on intracavitary radiation in the treatment of bladder tumors. J Urol 1981; 126:323
Hicks RM: Multistage carcinogenesis in the urinary bladder. Br Med Bull 1980; 36:39
Hicks RM, Chowaniec J, Wakefield J: Experimental induction of bladder tumors by a two-stage system. Pages 475–489 in: Carcinogenesis: Mechanisms of Tumor Promotion and Cocarcinogenesis. Vol 2. Slaga TJ, Sivak A, Boutwell RK (editors). Raven, 1978
Hope-Stone HF et al: T3 bladder cancer: Salvage rather than elective cystectomy after radiotherapy. Urology 1984; 24:315
International Union Against Cancer: TNM Classification of Malignant Tumors, 3rd ed. International Union Against Cancer, 1978
Itzchak Y, Singer D, Fischelavitch Y: Ultrasonographic assessment of bladder tumors. 1. Tumor detection. J Urol 1981; 126:31
Jakse G, Hofstädter F, Marberger H: Topical doxorubicin hydrochloride therapy for carcinoma in situ of bladder: A follow-up. J Urol 1984; 131:41
Javadpour N: Current status of biological markers in bladder and testis cancer. Lesson 13 in: American Urological Association Update Series. Vol 1. American Urological Association, 1982
Jewett HJ, Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 1946; 55:366
Johnson DE: Surgery for carcinoma of the urinary bladder. Cancer Treat Rev 1974; 1:271
Klein FA et al: Flow cytometry of normal and nonneoplastic diseases of the bladder: An estimate of the false-positive rates. J Urol 1982; 127:946
Koss LG: Tumors of the Urinary Bladder, Fascicle II of: Atlas of Tumor Pathology, 2nd series. Armed Forces Institute of Pathology, 1975
Lamm DL: Bacillus Calmette-Quérin-immunotherapy for bladder cancer. J Urol 1985; 134:40
Lamm DL et al: Complications of bacillus Calmette-Quérin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986; 135:272
La Plante M, Brice M II: The upper limits of hopeful application of radical cystectomy for vesical carcinoma: Does nodal metastasis always indicate incurability? J Urol 1973; 109:261
Lerman RI, Hutter RVP, Whitmore WF Jr: Papilloma of the urinary bladder. Cancer 1970; 25:333
Logothesis CJ et al: Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. J Urol 1985; 134:460
Marshall VF: The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 1952; 68:174
Martínez-Piñeiro JA: BCG vaccine in superficial bladder tumors: Eight years later. Eur Urol 1984; 10:93
Masina F: Segmental resection for tumours of the urinary bladder: Ten year follow-up. Br J Surg 1965; 52:279
Mathur VK, Krahn HP, Ramsey EW: Total cystectomy for bladder cancer. J Urol 1981; 125:784
McAninch JW, Kiesling VJ, Beck PN: Diagnostic biopsies of bladder and urethra in outpatients. Page 19 in: Proceedings of the Kimbrough Urological Seminar. Vol 12. Brodock Press, 1978
Meyers FJ et al: Fate of bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: Northern California oncology group study. J Urol 1985; 134:1118
Miller LS, Johnson DE: Megavoltage irradiation for bladder cancer: Alone, postoperative, or preoperative. Pages 771–782 in: Seventh National Cancer Conference Proceedings, Lippincott, 1973
Montie JE, Straffon RA, Stewart BH: Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984; 131:477
Morrison AS, Buring JE: Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med 1980; 302:537
Mostofi FK: Pathology and staging of bladder cancer. Pages 213–218 in: Advances in Medical Oncology, Research and Education. Vol 11: Clinical Cancer: Principal Sites 2. Wilkinson PM (editor). Pergamon, 1979
Mostofi FK, Sobin LH, Toriini H: Histological Typing of Urinary Bladder Tumours. World Health Organization, 1973
Newell GR, Hoover RN, Kolbye AC: Status report on saccharin in humans. J Natl Cancer Inst 1978; 61:275
Nseyo UO et al: Whole bladder photodynamic therapy for transitional cell carcinoma of bladder. Urology 1985; 26:274
Ojeda L, Johnson DE: Partial cystectomy: Can it be incorporated into an integrated program? Urology 1983; 12:115
Periss JA, Waterhouse K, Cole AT: Complications of partial cystectomy in patients with high grade bladder carcinoma. J Urol 1977; 118:761
Pinsky CM et al: Intravesical administration of bacillus Cal-mette-Quérin in patients with recurrent superficial carcinoma of the urinary bladder: Report of a prospective, randomized trial. Cancer Treat Rep 1985; 69:47
Purtilo DT et al: Familial urinary bladder cancer. Semin Oncol 1979; 6:254
Resnick MI, Kursh ED: Transurethral ultrasonography in bladder cancer. J Urol 196; 135:253
Resnick MI, O’Conor VJ Jr: Segmental resection for carcinoma of the bladder: Review of 102 patients. J Urol 1973; 109:1007
Rider WD, Evans DH: Radiotherapy in the treatment of recurrent bladder cancer. Br J Urol 1976; 48:595
Sandberg AA: Chromosome studies in bladder cancer. Pages 127–141 in: Carcinoma of the Bladder. Connolly JG (editor). Raven, 1981
Schellhammer PF, Ladaga LE, Fillion MB: Bacillus Call-mette-Quérin for superficial transitional cell carcinoma of bladder. J Urol 1986; 135:261
Shipley WU, Rose MA: Bladder cancer: The selection of patients for treatment by full-dose irradiation. Cancer 1985; 55:2278
Silverberg E: Cancer statistics, 1981, CA 1981; 31:13
Soloway MS: Treatment of superficial bladder cancer with intravesical mitomycin C: Analysis of immediate and long-term response in 70 patients. J Urol 1985; 134:1107
Stein BS et al: Specific red cell adherence: Immunologic evaluation of random mucosal biopsies in carcinoma of the bladder. J Urol 1981; 126:37
Sternberg CN et al: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985; 133:403
Utz DC, Farrow GM: Management of carcinoma in situ of the bladder: The case for surgical management. Urol Clin North Am 1980; 7:533
Utz DC et al: A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder. Cancer 1973; 32:1075
van der Werf-Messing B: Cancer of the urinary bladder treated by intestitial radium implant. Int J Radiat Oncol Biol Phys 1978; 4:373
van der Werf-Messing B: Carcinoma of the bladder T3N2M0 treated by preoperative irradiation followed by cystectomy: Third report of the Rotterdam Radio-Therapy Institute. Cancer 1975; 36:718
Veenema RJ et al: Bladder carcinoma treated by direct instillation of thiotepa. J Urol 1962; 88:60
Veenema RJ et al: Thiotepa bladder instillations: Therapy and prophylaxis for superficial bladder tumors. J Urol 1969; 101:711
Wallace DM, Bloom HJG: The management of deeply infiltrating (T3) bladder carcinoma: Controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy. Br J Urol 1976; 48:587
Whitmore WF Jr: Integrated irradiation and cystectomy for bladder cancer. Br J Urol 1980; 52:1
Wigle DT: Bladder cancer: Possible new high-risk occupation. Lancet 1977; 2:83
Wynder EL, Goldsmith K: The epidemiology of bladder cancer: A second look. Cancer 1977; 40:1246
Zincke H et al: Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease. Br J Urol 1985; 57:156
Prostatatumoren
Armenian HK et al: Relationship between benign prostatic hyperplasia and cancer of the prostate. Lancet 1974; 2:115
Franks LM: Benign nodular hyperplasia of the prostate: A review. Ann R Coll Surg Engl 1954; 14:92
Geraghty JT: Treatment of malignant disease of the prostate and bladder. J Urol 1922; 7:33
Greenwald P et al: Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 1974; 53:335
Hodges CV, Wan ST: The relationship between benign prostatic hyperplasia and prostatic carcinoma. Pages 167–173 in: Benign Prostatic Hypertrophy. Hinman F Jr (editor). Springer-Verlag, 1983
Lowsley OS: The development of the human prostate gland with reference to the development of the other structures at the neck of the urinary bladder. Am J Anat 1912:13:299
McNeil JE: Regional morphology and pathology of the prostate. Prostate 1981; 2:35.
Gutartige Prostatahyperplasie
Andersen JT, Nording J: Prostatism. 1. The correlation between symptoms: Cystometric and urodynamic findings. Scand J Urol Nephrol 1979; 13:229
Cabot AT: The question of castration for enlarged prostate. Ann Surg 1896; 24:265
Caine M, Perlberg S, Gordon R: The treatment of benign prostatic hypertrophy with flutamide (SCH 13521): A placebo-controlled study. J Urol 1975; 114:564
Caine M, Perlberg S, Meretyk S: A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol 1978; 50:551
Donkervoort TK et al: Megestrol acetate in treatment of benign prostatic hypertrophy. Urology 1975; 6:580
Geller J et al: Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy. Urology 1979; 14:467
Huggins C, Stevens RA: The effect of castration on benign hypertrophy of the prostate in man. J Urol 1940:43:705
Lytton B, Emery JM, Harvard BM: The incidence of benign prostatic obstruction. J Urol 1968; 99:639
Mebust WK, Valk WL: Transurethral prostatectomy. Pages 829–846 in: Benign Prostatic Hypertrophy. Hin-man F Jr (editor). Springer-Verlag, 1983
Melchior J et al: Transurethral prostatectomy: Computerized analysis of 2.223 consecutive cases. J Urol 1974; 112:634
Melchior J et al: Transurethral prostatectomy in the azotemic patient. J Urol 1974; 112:643
Neubauer DL: Endocrine and cellular inductive factors in the development of human benign prostatic hypertrophy. Pages 179–192 in: Benign Prostatic Hypertrophy. Hin-man F Jr (editor). Springer-Verlag, 1983
Scott WW, Wade JC: Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate. J Urol 1969; 101:81
Walsh A et al: Indications for prostatectomy: Mandatory and optional. Pages 771–775 in: Benign Prostatic Hypertrophy. Hinman F Jr (editor). Springer-Verlag, 1983
Walsh PC, Hutchins GM, Ewing LL: Tissue content of dehydrotestosterone in human prostatic hyperplasia is not supranormal. J Clin Invest 1983; 72:1772
White JW: The results of double castration in hypertrophy of the prostate. Ann Surg 1895; 22:1
Prostatakarzinom
Bagshaw MA: Radiotherapy of prostatic cancer: Stanford University experience. Prog Clin Biol Res 1984; 153:493
Bass RB Jr, Barrett DM: Radical retropubic prostatectomy after transurethral prostatic resection. J Urol 1980; 124:495
Bonar RA: Carcinogenesis in urogenital tissues in genitourinary cancer. In: Cancer Treatment and Research. Vol 6. Paulson DF (editor). Martinus Nijhoff, 1982
Brackman J, Denis L: The practice and pitfalls of ultrasonography in the lower urinary tract. Eur Urol 1983; 9:193
Brawn PN et al: Histologic grading study of prostatic adenocarcinoma: The development of a new system and comparison with other methods. A preliminary study. Cancer 1982; 49:525
Bridges CH et al: Stage A prostatic carcinoma and repeat transurethral resection: A reappraisal 5 years later. J Urol 1983; 129:307
Broder AC: Carcinoma grading and practical applications. Arch Pathol 1926; 2:376
Byar DP: Survival of patients with incidentally found microscopic cancer of the prostate: Results of a clinical trial of conservative treatment. J Urol 1972; 108:908
Byar DP, Mostofi FK, Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 1972; 30:5
Catalona WJ, Stein AJ: Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. J Urol 1982; 127:460
Clark P, Houghton L: Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 1977; 49:419
Cox JD, Stoffel TJ: The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 1977; 40:156
Foti AG et al: The detection of prostatic cancer by solid phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 1977; 297:1357
Franks LM: Latent carcinoma of the prostate. J Urol Pathol Bacteriol 1954; 68:603
Freiha FS, Bagshaw MA: Carcinoma of the prostate: Results of postirradiation biopsy. Prostate 1984; 5:19
Freiha FS, Pistenma DA, Bagshaw MA: Pelvic lymph-adenectomy for staging prostatic carcinoma: Is it always necessary? J Urol 1979; 122:176
Gagnon JD, Moss WT, Stevens KR: Preestrogen breast irradiation for patients with carcinoma of the prostate: A critical review. J Urol 1979; 121:182
Gleason DF, Mellinger GT: Veterans Administration Cooperative Urologic Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58
Guerriero WG, Carlton CE Jr, Hudgins PT: Combined interstitial and external radiotherapy in the definitive management of carcinoma of the prostate. Cancer 1980; 45:1922
Hanash KA et al: Carcinoma of the prostate: A 15 year follow-up. J Urol 1972; 107:450
Herr HW: Complication of pelvic lymphadenectomy and retropubic prostatic 125I implantation. Urology 1979; 14:226
Hirayama T: Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979; 53:149
Jacobs SC: Spread of prostatic cancer to bone. Urology 1983; 21:337
Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975; 2:105
Johnson DE, von Eschenbach AC: Prostatic carcinoma: A trilogy of expressions. South Med J 1980; 73:1304
Johnson DE, von Eschenbach AC: Role of lymphangiography and pelvic lymphadenectomy in staging prostatic carcinoma. J Urol 1981; 17 (Suppl):66
Jordan WP Jr, Blackard CE, Byar DP: Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South Med J 1977; 70:1411
Kuriyama M et al: Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. J Natl Cancer Inst 1982; 68:99
Labrie F et al: New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens. Prostate 1983; 4:579
Lee F et al: Transrectal ultrasound in the diagnosis of prostate carcinoma: Location, echogenicity, histopathology, staging. Prostate 1985; 7:117
Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984; 311:1281
Logothetis CJ et al: Doxorubicin, mitomycin C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal-refractory adenocarcinoma of the prostate, with a note on the staging of metastatic cancer. J Clin Oncol 1983; 1:368
McLaughlin AP et al: Prostatic carcinoma: Incidence and location of unsuspected lymphatic metastases. J Urol 1976; 115:89
McMilien SM, Wettlaufer JN: The role of repeat transurethral biopsy in stage A carcinoma of the prostate. J Urol 1976; 116:759
Middleton RG, Smith JA Jr: Radical prostatectomy for stage B2 prostatic cancer. J Urol 1982; 127:702
Mostofi FK: Grading of prostatic carcinoma. Cancer Chemother Res 1975; 59:111
Murphy GP: Chemotherapy of advanced prostatic cancer. Rev Surg 1977; 34:75
Nesbitt RM, Baum WC: Endocrine control of prostatic carcinoma. JAMA 1950:143:1317
Nichols RT, Barry JM, Hodges CV: The morbidity of radical prostatectomy for multifocal stage I prostatic adenocarcinoma. J Urol 1977; 117:83
Paulson DF, Urologic Oncology Research Group: The impact of current staging procedures in assessing disease extent of prostatic carcinoma. J Urol 1979; 121:300
Rich AR: On the frequency of occurrence of occult carcinoma of the prostate. J Urol 1935; 33:215
Rotkin ID: Epidemiologic studies in prostatic cancer. Cancer Treat Rep 1977; 61:173
Schroeder FH, Belt E: Carcinoma of the prostate: A study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 1975; 114:257
Seamonds B et al: Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology 1986; 28:472
Sheldon CA et al: Incidental carcinoma of the prostate: A review of the literature and critical appraisal of classification. J Urol 1980; 124:626
Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: A continuing cooperative study. J Urol 1964; 91:590
Walsh PC: Physiologic basis for hormonal therapy in carcinoma of the prostate. Urol Clin North Am 1975; 2:125
Walsh PC, Donker PJ: Impotence following radical prostatectomy. J Urol 1982; 128:492
Walsh PC, Jewett HJ: Radical surgery for prostatic cancer. Cancer 1980; 45 (Suppl 7): 1906
Whitmore WF Jr: Hormone therapy in prostatic cancer. Am J Med 1956; 21:697
Whitmore WF Jr: The natural history of prostatic cancer. Cancer 1973; 32:1104
Whitmore WF Jr, Hilaris B, Grabstald H: Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J Urol 1972; 109:918
Winkelstein W Jr, Ernster VL: Epidemiology and etiology in prostatic cancer. Page 1 in: Prostatic Cancer. Murphy GP (editor). PSG Publishing, 1979
Zincke H et al: Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer 1981; 47:1901
Tumoren der Prostatagänge
Dube VE, Farrow GM, Greene LF: Prostatic adenocarcinoma of ductal origin. Cancer 1973; 32:402
Greene LF et al: Prostatic adenocarcinoma of ductal origin. J Urol 1979; 121:303
Tumoren der Samenblasen
Lathem JE: Carcinoma of seminal vesicle. South Med J 1975; 68:473
Tumoren der Urethra
Bracken RB, Henry R, Ordonez N: Primary carcinoma of the male urethra. South Med J 1980; 73:1003
Grabstald H et al: Cancer of the female urethra. JAMA 1966; 197:835
Johnson DE, O’Connell JR: Primary carcinoma of the female urethra. Urology 1983; 12:115
Johnson DE, O’Connell JR, Delclos L: Cancer of the urethra. In: Principles and Management of Urologic Cancer, 2nd ed. Javadpour N (editor). Williams & Wil-kins, 1983
Johnson DE et al: Rotational skin flaps to cover wound defect in groin. Urology 1975; 6:461
Marshall FC, Uson AC, Melicow MM: Neoplasms and caruncles of the female urethra. Surg Gynecol Obstet 1960; 110:723
Ray B, Guinan PD: Primary carcinoma of the urethra. In: Principles and Management of Urologic Cancer. Javadpour N (editor). Williams & Wilkins, 1979
Shuttleworth KED, Lloyd-Davies RW: Radical resection for tumors invading the posterior urethra. Br J Urol 1969; 41:739
Zeigerman JH, Gordon SF: Cancer of the female urethra: A curable disease. Obstet Gynecol 1970; 36:785
Tumoren des Samenstrangs und des paratestikulären Gewebes
Adrien M, Grabstald H, Whitmore WF Jr: Malignant tumors of the spermatic cord. Cancer 1969; 23:525
Banowsky LH, Schultz GN: Sarcoma of the spermatic cord and tunica: Review of the literature, case report and discussion of the role of retroperitoneal lymph node dissection. J Urol 1970; 103:628
Johnson DE, Harris JD, Ayala AG: Liposarcoma of spermatic cord Urology 1978; 11:190
Johnson RB Jr et al: Paratesticular rhabdomyosarcoma in childhood. Cancer 1978; 42:729
Wertzner S: Leiomyosarcoma of the spermatic cord and uteroperitoneal lymph node dissection. Am Surg 1973; 39:352 Hodentumoren
Babaian RJ, Johnson DE: Management of stage I and II nonseminomatous germ cell tumors of the testis. Cancer 1980; 45:1775
Ball D, Barrett A, Peckham MJ: The management of metastatic seminoma testis. Cancer 1982; 50:2289
Belville WD et al: The liver scan in urologic oncology. J Urol 1980;123:901
Berthelsen JG et al: Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J 1982; 285:1683
Boden G, Ribb R: Radiotherapy in testicular neoplasms. Lancetz 1951; 2:1195
Borski AA: Diagnosis, staging and natural history of testicular tumor. Cancer 1973; 32:1202
Bowman WP et al: Isolated testicular relapse in acute lymphocytic leukemia of childhood: Categories and influence on survival. J Clin Oncol 1984; 2:924
Bracken RB et al: The role of surgery following chemotherapy in stage III germ cell neoplasms. J Urol 1983; 129:39
Braunstein GD et al: Ectopic production of human chorionic gonadotropin by neoplasms. Ann Intern Med 1973; 78:39
Caldwell WL: Why retroperitoneal lymphadenectomy for testicular tumors? J Uro 1978; 119:754
Cancer Facts and Figures, 1979, American Cancer Society, 1978
Collins DH, Pugh RCB: Classification and frequency of testicular tumors. Br J Urol 1964; 36 (Suppl): 1
Dixon FH, Moore RA: Tumors of the Male Sex Organs, Armed Forces Institute of Pathology, 1952
Donohue JP, Rowland RG: The role of surgery in advanced testicular cancer. Cancer 1984; 54:2716
Donohue JP, Einhorn LH, Williams SD: Cytoreductive surgery for metastatic testis cancer: Considerations of timing and extent. J Urol 1980; 123:876
Donohue JP, Einhorn LH, Williams SD: Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testicular cancer necessary? Urol Clin North Am 1980; 7:747
Donohue JP, Zachary JM, Maynard BR: Distribution of total metastases in nonseminomatous testis cancer. J Urol 1982;128:315
Donohue JP et al: Cytoreductive surgery for metastatic testicular cancer: Analysis of retroperitoneal masses after chemotherapy. J Urol 1982; 127:1111
Forrest JB, Sabio H, Howards SS: Testicular relapse in acute childhood leukemia. J Surg Oncol 1982; 21:132
Freiha FS et al: The extent of surgery after chemotherapy for advanced germ cell tumors. J Urol 1984; 132:915
Friedman EL et al: Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 1985; 3:1325
Friedman NB, Moore RA: Tumors of the testis: A report of 922 cases. Milit Med 1946; 99:573
Gallager HS: Pathology of testicular and peritesticular neoplasms. Pages 1–30 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976
Hoskin P et al: Prognostic factors in stage I Nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: Implications for adjuvant chemotherapy. J Clin Oncol 1986; 4:1031
Hudson MM et al: Diagnostic value of surgical testicular biopsy after therapy for acute lymphocytic leukemia. J Pediatr 1985; 107:50
Javadpour N: Tumor markers in urologic cancer. Urology 1980; 16:127
Javadpour N, Moley J: Alternative to retroperitoneal lymphadenectomy with preservation of ejaculation and fertility in stage I nonseminomatous testicular cancer: A prospective study. Cancer 1985; 55:1604
Javadpour N et al: The role of radioimmunodetection in the management of testicular cancer. JAMA 1981; 246:45
Jeppsson A et al: A clinical evaluation of serum placental alkaline phosphatase in seminoma patients. Br J Urol 1983; 55:73
Johnson DE: Clinical staging. Pages 131–144 in: Testis Tumors. Donohue JP (editor). Williams & Wilkins, 1983
Johnson DE: Epidemiology. Pages 37–46 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976
Johnson DE, Ayala AG: Secondary neoplasms of the testis. Pages 249–260 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976
Johnson DE, Bracken RB, Blight EM: Prognosis for pathologic stage I nonseminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy. J Urol 1976; 116:63
Johnson DE, Butler JJ: Malignant lymphoma of the testis. Pages 234–248 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976
Johnson DE, Gomez JJ, Ayala AG: Anaplastic seminoma. J Urol 1975; 114:80
Johnson DE et al: Metastases from testicular carcinoma: Study of 78 autopsied cases. Urology 1976; 8:234
Johnson DE et al: Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: Preliminary results. J Urol 1984; 131:491
Kaswick JA, Bloomberg SD, Skinner DG: Radical retroperitoneal lymph node dissection: How effective is removal of all retroperitoneal nodes? J Urol 1976; 115:70
Kim I, Young RH, Scully RE: Leydig cell tumors of the testis: A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 1985; 9:177
Klein FA, Melamed MR, Whitmore WF Jr: Intratubular malignant germ cells (carcinoma in situ) accompanying invasive testicular germ cell tumors. J Urol 1985; 133:413
Kreuser ED et al: Bulky germinal tumors: Comparison of different induction regimens and significance of residual disease. Eur Urol 1985; 11:163
Lange PH et al: Is SP-1 a marker for testicular cancer? Urology 1980; 15:251
Li SP, Connelly RR, Myers M: Improved survival rates among testicular cancer patients in the US. JAMA 1982; 247:825
Logothetis CJ et al: The growing teratoma syndrome. Cancer 1982; 50:1629
Logothetis CJ et al: Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. J Clin Oncol 1985; 3:326
Logothetis CJ et al: Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: A preliminary report. J Urol 1985; 134:1127
Melicow MM: The British classification of testicular tumors: A correlation, analysis and critique. J Urol 1965; 94:64
Mills PK, Newell GR, Johnson DE: Familial patterns of testicular cancer. Urology 1984; 24:1
Niruyana B et al: Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis: Importance in “surveillance only” protocols. Cancer 1985; 56:2492
Mostofi SK: Testicular tumors: Epidemiologic, etiologic, and pathologic features. Cancer 1973; 32:1186
Mostofi SK, Price RB Jr: Tumors of the Male Genital System. Armed Forces Institute of Pathology, 1973
Mostofi SK, Sobin LH: International Histologic Classification of Tumors. No. 16. Histological Typing of Testis Tumors. World Health Organization, 1977
Müller J et al: Cryptorchidism and testis cancer: A typical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer 1984; 54:629
Patterson AHG, Peckham MJ, McCready VR: Value of gallium-scanning in seminoma of the testis. Br Med J 1977; 1:1118
Patton JF, Mallis N: Tumors of the testis. J Urol 1959; 81:457
Pearson JC: Endocrinology of testicular neoplasms. Urology 1981; 17:119
Peckham MJ, Hendry WF: Clinical stage II nonseminomatous germ cell testicular tumours: Results of management by primary chemotherapy. Br J Urol 1985; 57:763
Pierce GB: Ultrastructure of human testicular cancer. Cancer 1966; 19:1963
Pizzocaro G, Monfardini S: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 1984; 131:677
Pizzocaro G, Salvioni R, Zanoni F: Unilateral lymph-adenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol 1985; 134:485
Pizzocaro G et al: Surveillance or lymph node dissection in clinical stage I nonseminomatous germinal testis cancer? Br J Urol 1985; 57:759
Pui CH et al: Elective testicular biopsy during chemotherapy for childhood leukaemia is of no clinical value. Lancet 1985; 2:410
Richie JP, Garnick MB: Limited retroperitoneal lymph-adenectomy for patients with clinical stage I testicular tumor. (Abstract.) Proc Am Soc Clin Oncol 1985; 4:110
Rosai J, Silber I, Khodadoust K: Spermatocytic seminoma. 1. Clinicopathologic study of six cases and review of the literature. Cancer 1969; 24:92
Rosai J, Khodadoust K, Silber I: Spermatocytic seminoma. 2. Ultrastructural study. Cancer 1969; 24:103
Rouviere H: Anatomie de lymphatiques de l’homme. Maison et Cie, 1932
Safer ML et al: Lymphangiographic accuracy in the staging of testicular tumors. Cancer 1975; 35:1603
Samuels ML et al: Combination chemotherapy in germinal tumors. Cancer Treat Rev 1976; 3:185
Scardino PT: Adjuvant chemotherpay is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors. Urol Clin North Am 1980; 7:735
Schover LR, von Eschenbach AC: Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 1985; 25:251
Sogani PC et al: Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 1984; 2:267
Stevens LC: Origin of testicular teratoma from primordial germ cells in mice. J Natl Cancer Inst 1967; 138:549
Stoter G et al: Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin. Cancer 1984; 54:1521
Sussman EB et al: Malignant lymphoma of the testis: A clinical pathologic study of 37 cases. J Urol 1977; 17:1004
Swanson DA: Benefits of early diagnosis of testis cancer. Cancer Bull 1985; 37:291
Swartz DA, Johnson DE, Hussey DH: Should an elevated human chorionic gonadotropin titer alter therapy for seminoma? J Urol 1984; 131:63
Tait D et al: Postchemotherapy surgery in advanced nonseminomatous germ-cell testicular tumours: The significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 1984; 50:601
Talerman A: The incidence of yolk sac tumor (endodermal sinus tumor) elements in germ cell tumors of the testis in adults. Cancer 1975; 33:211
Talerman A, Fu YS, Okagaki T: Spermatocytic seminoma: Ultrastructural and microspectrophotometric observations. Lab Invest 1984; 51:343
Teilum G: The concept of endodermal sinus (yolk sac) tumor. Scand J Immunol 1978; 8 (Suppl):75
Templeton AC: Testicular neoplasms in Ugandan Africans. Afr J Med Sci 1972; 3:157
Thomas GM: Controversies in the management of testicular seminoma. Cancer 1985; 55 (9 Suppl):2296
Thomas GM et al: Seminoma of the testis: Results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys 1982; 8:165
Turner RR, Colby TV, MacKintosh FR: Testicular lymphomas: A clinical pathologic study of 35 cases. Cancer 1981; 48:2095
Tyrrell CJ, Peckham MJ: The response of lymph node metastases of testicular teratoma to radiation therapy. Br J Urol 1976; 48:363
Valvo JR, Wilson P, Frank IN: Ultrasonic examination of scrotum: Review of 108 cases. Urology 1983; 22:78
Vugrin D, Whitmore WF Jr: The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer. Cancer 1985; 55:1874
Vugrin D, Whitmore WF Jr: The VAB-6 regimen in the treatment of metastatic seminoma. Cancer 1984; 53:2422
Vugrin D et al: Adjuvant chemotherapy in non-seminoma-tous testis cancer: “Mini-VAB” regimen. Long-term follow-up. J Urol 1981; 126:49
Vugrin D et al: VAB-6 combination chemotherapy in resected II-B testicular cancer. Cancer 1983; 51:5
Waldmann TA, McIntire KR: The use of radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974; 34:1510
Wallace S et al: Lymphangiograms: Their diagnosis and therapeutic potential. Radiology 1961; 76:179
Whitmore WF Jr: Surgical treatment of clinical stage I non-seminomatous germ cell tumors of the testis. Cancer Treat Rep 1982; 66:5
Williams SD, Einhorn LH: Clinical stage I testis tumor: The medical oncologist’s view. Cancer Treat Rep 1982; 66:15
Willis RA: Pathology of Tumors. Appleton-Century-Crofts, 1967
Extragonadale Keimzelltumoren
Buskirk SJ et al: Primary retroperitoneal seminomas. Cancer 1982; 49:1934
Israel A et al: The results of chemotherapy for extra-gonadal germ-cell tumors in the cisplatin era: The Memorial Sloan-Ketiering Cancer Center experience (1975 to 1982). J Clin Oncol 1985; 3:1073
Jain KK et al: The treatment of extragonadal seminoma. J Clin Oncol 1984; 2:820
Logothetis CJ et al: Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1985; 3:316
Luna MA: Extragonadal germ cell tumors. Pages 261–265 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976
Meares EM Jr, Briggs EM: Occult seminoma masquerading as primary extragonadal germinal neoplasms. Cancer 1972; 30:300
Nebenhodentumoren
Farrell MA, Donnelly BJ: Malignant smooth muscle tumors of the epididymis. J Urol 1980; 124:151
Mostofi FK, Price EB Jr: Tumors of the Male Genital System. Armed Forces Institute of Pathology, 1973
Penistumoren
Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977; 39:456
Cartwright RA, Sinson JD: Carcinoma of the penis and cervix. Lancet 1980; 1:97
Delclos L: Interstitial irradiation of the penis. Pages 219–225 in: Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Johnson DE, Boileau MA (editors). Grune & Stratton, 1982
Duncan W, Jackson SM: The treatment of early cancer of the penis with megavoltage X-rays. Clin Radiol 1972; 23:246
Jackson SM: The treatment of carcinoma of the penis. Br J Surg 1966; 53:33
Johnson DE, Ames FC: Groin Dissection Doody DJ (editor). Year Book, 1985
Johnson DE, Lo RK: Complications of groin dissection in prenile cancer: Experience with 101 lymphadenectomies. Urology 1984; 24:312
Johnson DE, Lo RK: Management of regional lymph nodes in penile carcinoma: Five-year results following therapeutic groin dissections. Urology 1984; 24:308
Johnson DE et al: Verrucous carcinoma of the penis. J Urol 1985; 133:216
Persky L: Epidemiology of the penis. Pages 97–109 in: Tumors of the Male Genital System. Grundmann E, Vah-lensieck W (editors). Springer, 1977
Puras A, Gonzalez-Flores B, Rodriguez R: Treatment of carcinoma of the penis. Pages 143–152 in: Proceedings of the Kimbrough Urological Seminar. Stevenson HG (editor). Brodock Press, 1977
Reddy DG, Baruah IKSM: Carcinogenic action of human smegma. Arch Pathol 1963; 75:414
Tumoren des Skrotums
McDonald MW: Carcinoma of the scrotum. Urology 1982; 19:269
Ray B, Whitmore WF Jr: Experience with carcinoma of the scrotum. J Urol 1977; 117:741
Extrarenale retroperitoneale Tumoren
Binder SC, Katz B, Sheridan B: Reproperitoneal liposar-coma. Ann Surg 1978; 187:257
Damascelli B et al: Angiography of retroperitoneal tumors: A review. Am J Roentgenol 1975; 124:565
Duncan RE, Evans AT: Diagnosis of primary retroperitoneal tumors. J Urol 1977; 117:19
Kinne DW et al: Treatment of primary and recurrent retroperitoneal liposarcoma: Twenty-five year experience at Memorial Hospital. Cancer 1973; 31:53
Polsky MS et al: Retrovesical liposarcoma. Urology 1974; 3:226
Sadoughi N et al: Retroperitoneal xanthogranuloma. Urology 1973; 1:470
Smith EH, Bartum RJ Jr: Ultrasonic evaluation of pararenal masses. JAMA 1975; 231:51
Stephans DH et al: Computed tomography of the retroperitoneal space. Radiol Clin North Am 1977; 15:377
Stephens DH et al: Diagnosis and evaluation of retroperitoneal tumors by computed tomography. AJR 1977; 129:395
Chemotherapie bösartiger urologischer Erkrankungen Allgemeine Literatur
Bagshawe KD (editor): Medical Oncology. Blackwell, 1975
Bodansky O: Biochemistry of Human Cancer. Academic Press, 1975
Brodsky I, Kahn SB, Moyer JH: Cancer Chemotherapy: Basic and Clinical Applications. (Twenty-Second Hahnemann Symposium). Grune & Stratton, 1972
Carter SK et al: Chemotherapy of Cancer. Wiley, 1977
Cline MJ, Haskell CM III: Cancer Chemotherapy; 3rd ed. Saunders, 1980
Criss WE, Ono T, Sabine JR (editors): Control Mechanisms in Cancer. Raven Press, 1976
De Vita VT Jr, Hellman S, Rosenberg S: Cancer: Principles and Practice of Oncology. Lippincott, 1982
Dunphy JE: On caring for the patient with cancer. N Engl J Med 1976; 295:313
Haskell CM: Cancer Treatment. Saunders, 1980
Holland JF, Frei E III (editors): Cancer Medicine. Lea & Febiger, 1973
Horton J, Hill GJ II (editors): Clinical Oncology. Saunders, 1977
Jones SE, Salmon SE (editors) Adjuvant Therapy of Cancer II. Grune & Stratton, 1977
Krakoff IHG: Cancer chemotherapeutic agents. CA 1977; 27:130
Krakoff IH: (editor): Symposium on medical aspects of cancer. Med Clin North Am 1971; 55:525. [Entire issue.]
Lawrence W Jr, Terz JJ (editors): Cancer Management. Grune & Stratton, 1977
Moss WT, Brand WN, Battifora H: Radiation Oncology. Mosby, 1979
Munster AM (editor): Surgical Immunology. Grune & Stratton. 1976
Nealon TF Jr (editor): Management of the Patient With Cancer, 2nd ed. Saunders, 1976
Noskell CM: Cancer Treatment. Saunders, 1980
Salmon SE: Cancer chemotherapy. Chap 45, pp 477–513, in: Review of Medical Pharmacology, 7th ed. Lange, 1980
Salmon SE, Jones SE (editors): Adjuvant Therapy of Cancer. Vol 3, Grune & Stratton, 1981
Van Der Veer LD Jr, Balini JA: Chemotherapy of gastrointestinal malignancy. Am J Gastroenterol 1980; 74:40
Veidenheimer MC (editor): Symposium on the care and treatment of the cancer patient. Surg Clin North Am 1967; 47:557
Ätiologische Faktoren bei der Tumorbildung
Allen DW et al: Viruses and human cancer. N Engl J Med 1972; 286:70
American Cancer Society: Second National Conference on Diet, Nutrition, and Cancer. Cancer 1986; 59 (Suppl): 1791
Bast RC Jr et al: BCG and cancer. (2 parts.) N Engl J Med 1974; 290:1413
Bootwell R: Tumor promoters in human carcinogenesis. Pages 16–27 in: Important Advances in Oncology 1985. De Vita VT, Hellman S, Rosenberg SA (editors). Lippincott, 1985
Durack DT: Opportunistic infections and Kaposi’s sarcoma in homosexual men. (Editorial.) N Engl J Med 1981; 305:1465
Farber E: Chemical carcinogenesis. N Engl J Med 1981; 305:1379
Gallo RC: RNA-dependent DNA polymerase in viruses and cells. Blood 1972; 39:117
Gofman JW, Tamplin AR: Radiation, cancer, and environmental health. Hosp Pract (Oct) 1970; 5:91
Greenwald P, Ershow AG, Novelli WD (editors): Cancer Diet, and Nutrition: A Comprehensive Sourcebook. Who’s Who, Inc., 1985
Grobstein C (editor): Diet, Nutrition and Cancer. National Academy Press, 1982
Ryser HJP: Chemical carcinogenesis. N Engl J Med 1971; 285:721
Smith RT: Possibilities and problems of immunologic intervention in cancer. N Engl J Med 1972; 287:439
Zamcheck N et al: Immunologic evaluation of human digestive tract cancer: Carcinoembryonic antigens. N Engl J Med 1972; 286:83
Aids
Allen JR: Epidemiology of the acquired immunodeficiency syndrome (AIDS) in the United States. Semin Oncol 1984;11:4
Gallo RC et al: T cell malignancies and human T cell leukemia virus. Semin Oncol 1984; 11:12
Volberding P: Therapy of Kaposi’s sarcoma in AIDS. Semin Oncol 1984; 11:60
Onkogenese
Gordon H: Oncogenes. Mayo Clin Proc 1985; 60:697
Green AR, Wyke JA: Anti-oncogenes: A subset of regulatory genes involved in carcinogenesis? Lancet 1985; 2: 475
Solitärmetastasen
Adkins PC et al: Thoracotomy on the patient with previous malignancy: Metastasis of new primary? J Thorac Cardio-vasc Surg 1968; 56:361
Rubin P, Green J: Solitary Metastases. Thomas, 1968
Immuntherapie
Beutler B, Cerami A: Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986; 320:584
Gutterman JU et al: Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 1980; 93:399
Lotze MT et al: Monoclonal antibody imaging of human melanoma: Radioimmunodetection by subcutaneous or systemic injection. Ann Surg 1986; 204:223
Munster AM (editor): Surgical Immunology. Grune & Stratton, 1976
Pinsky CM et al: Biological response modifiers. Semin Oncol 1986; 13:131 [Entire issue]
Rosenberg SA, Speiss P, La Freniere R: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233:1318
Rosenberg SA et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485
Smith RT: Possibilities and problems of immunologic intervention in cancer. N Engl J Med 1972; 287:437
Terry WD (editor): Symposium on immunotherapy in malignant disease. Med Clin North Am 1976; 60:387. [Entire issue]
Terry WD, Windhorst D (editors): Immunotherapy of Cancer: Present Status of Trials in Man. Vol 6 of: Progress in Cancer Research and Therapy. Raven Press, 1978. [Entire volume.]
Vadhan-Raj S et al: Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol 1986; 4:137
Chemotherapie
Alberts DS: In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 1980; 2:340
Bergevin PR, Tormey DC, Blom J: Guide to the use of cancer chemotherapeutic agents. Mod Treat 1972; 9:185
Bergsagel DE: New perspectives in chemotherapy: Focus on Novantrone. Semin Oncol 1984; 11 (Suppl 1): 1. [Entire issue.]
Borgmann V et al: Treatment of prostatic cancer with LH-RH analogues. Prostate 1983; 4:553
Bruce WR et al: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 1966; 37:233
The choice of therapy in the treatment of malignancy. Med Lett Drugs Ther 1973; 15:9
De Vita VT: Cell kinetics and the chemotherapy of cancer. Cancer Chemother Rep 1971; 2:23
De Vita VT, Schein PS: The use of drugs in combination for the treatment of cancer. N Engl J Med 1973; 288:988
Holland JF: Karnofsky Memorial Lecture: Breaking the cure barrier. J Clin Oncol 1983; 1:75
Labrie F et al: New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens. Prostate 1983; 4:579
Livingston RB, Carter SK: Single Agents in Cancer Chemotherapy. Plenum Press, 1970
Philips NC, Lauper RD: Review of etoposide. Clin Pharm 1983; 2:112
Pinedo HM, Chabner BA (editors): Cancer Chemotherapy Annual. Elsevier, 1984
Rall DP (chairman): Design of more selective antitumor agents. Cancer Res 1969; 29:2384
Salmon SE (editor): Clinical correlation of drug sensitivity. Pages 265–285 in: Cloning of Human Tumor Stem-Cells. Liss, 1980
Salmon SE et al: Quantitation of differential sensitivities of human-tumor stem-cells to anti-cancer drugs. N Engl J Med 1978; 298:1231
Santen RJ et al: Long-term effects of administration of a gonadotropin-releasing hormone superagonist along in men with prostatic carcinoma. J Clin Endocrinol Metab 1984; 58:397
Schabel FM: The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors. Cancer Res 1969; 29:2384
Skipper HE et al: Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemother Rep 1970; 54:431
Spiegel RJ: Intron A (interferon a-2b): Clinical overview and future directions. Semin Oncol 1986; 13 (Suppl 2): 89
Valeriote FA, Edelstein MB: The role of cell kinetics in cancer chemotherapy. Semin Oncol 1977; 4:217
Adjuvante Chemotherapie
Bonnadonna G et al: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976; 294:405
Fisher B et al: L-Phenylalanine mustard (l-PAM) in the management of primary breast cancer: A report of early findings. N Engl J Med 1975; 292:117
Fisher F et al: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 1968; 168:337
Jones SE, Salmon SE (editors): Adjuvant Therapy of Cancer II. Grune & Stratton, 1977
Li MC et al: Chemoprophylaxis for patients with colorectal cancer. JAMA 1976; 235:2825
Mackman S, Curreri AR, Ansfield FS: Second look operation for colon carcinoma after fluorouracil therapy. Arch Surg 1970; 100:527
Infusions- und Perfusionstherapie
Ansfield FJ et al: Intrahepatic arterial infusion with 5-fluorouracil. Cancer 1971; 28:1147
Ensminger W et al: Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981; 65:393
Freckman HA: Chemotherapy for metastatic colorectal liver carcinoma by intra-aortic infusion. Cancer 1971; 28:1152
Goldstein HM et al: Transcatheter occlusion of abdominal tumors. Radiology 1976; 120:539
Krementz ET, Creech O Jr, Ryan RF: Evaluation of chemotherapy of cancer by regional perfusion. Cancer 1967; 20:834
Chemotherapeutische Kombinationsbehandlung
Carbone PP, Davis TE: Medical treatment for advanced breast cancer. Semin Oncol 1978; 5:417
DeVita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 1970; 73:881
DeVita VT Jr et al: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 1975; 35:98
Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87:293
Greenspan EM: Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma. Mt Sinai J Med NY 1966; 33:1
Li MC et al: Effects of combined drug therapy on metastatic cancer of the testis. JAMA 1960; 174:1291
Luce JK: Chemotherapy for lymphomas: Current status. Page 295 in: Leukemia-Lymphoma. Year Book, 1969
Samuels ML: Continuous intravenous bleomycin therapy with vinblastine in testicular and extragonadal germinal tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:112
Ungesicherte Behandlungsmethoden in der Krebstherapie
Herbert V: Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment. Cancer 1986; 58 (8 Suppl): 1930
Moertel CG et al: A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982; 306:201 Diagnostisches Vorgehen bei Patienten mit unbekanntem Primärtumor
Altman E, Cadman E: An analysis of 1539 patients with cancer of unknown primary site. Cancer 1986; 57:120
Brady LW et al: Unusual sites of metastases. Semin Oncol 1977; 4:59
Didolkar MS et al: Metastatic carcinomas from occult primary tumors: A study of 254 patients. Ann Surg 1977; 186:625
Greco FA, Oldham RK, Fer MF: The extragonadal germ cell cancer syndrome. Semin Oncol 1982; 9:448
Grosbach AB: Carcinoma of unknown primary site: A clinical enigma. Arch Intern Med 1982; 142:357
Karsell PR, Sheedy PF II, O’Connell MJ: Computed tomography in search of cancer of unknown origin. JAMA 1982; 248:340
Nystrom JS et al: Identifying the primary site in metastatic cancer of unknown origin: Inadequacy of roentgeno-graphic procedures. JAMA 1979; 241:381
Nystrom JS et al: Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 1977; 4:53
Osteen RT, Kopf G, Wilson RE: In pursuit of the unknown primary. Am J Surg 1978; 135:494
Woods RL et al: Metastatic adenocarcinomas of unknown primary site: A randomized study of two combination-chemotherapy regimens. N Engl J Med 1980; 303:87
Paraneoplastische Syndrome
Hall TC (editor): Paraneoplastic syndromes. Ann NY Acad Sci 1974; 230:1. [Entire issue.]
Waldenström JG: Paraneoplasia. Wiley, 1978
Neuroblastom
Evans AE et al: A review of 17IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer 1980; 45:833
Nierenzellkarzinom
Bloom HJG: Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973; 32:1066
Klippel KF, Altwein JE: Palliative Therapiemöglichkeiten beim metastasierten Hypernephrom. Dtsch Med Wo-chenschr 1979; 104:28
Krown SE: Therapeutic options in renal-cell carcinoma. Semin Oncol 1985; 12 (Suppl 5): 13
Lokich JJ, Harrison JH: Renal cell carcinoma: Natural history and chemotherapeutic experience. J Urol 1975; 114:371
Talley RW: Proceedings: Chemotherapy of adenocarcinoma of the kidney. Cancer 1973; 32:1062
Wilms-Tumor
Green DM, Jaffe N: Wilms’ tumor: Model of a curable pediatric malignant solid tumor. Cancer Treat Rev (Sept) 1978; 5:143
Übergangszellkarzinom
Carter SK: Chemotherapy and genitourinary oncology. 1. Bladder cancer. Cancer Treat Rev (June) 1978; 5:85
Hahn RG: Bladder cancer treatment considerations for metastatic disease. Semin Oncol 1979; 6:236
Koontz WW Jr: Intravesical chemotherapy and chemopre-vention of superficial, low grade, low stage bladder carcinoma. Semin Oncol 1979; 6:217
Prostatakarzinom
Mittelman A, Shukla SK, Murphy GP: Extended therapy of stage D carcinoma of the prostate with oral estramus-tine phosphate. J Urol 1976; 115:409
Torti FM, Carter SK: The chemotherapy of prostatic adenocarcinoma. Ann Intern Med 1980; 92:681
Hodenkarzinom
Cvitkovic E et al: Bleomycin (BLEO) infusion with cis-platinum diammine dichloride (CPDD) as secondary chemotherapy for germinal cell tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:273
Einhorn LH, Donohue JP: Combination chemotherapy in disseminated testicular cancer. Semin Oncol 1979; 6:87
Einhorn LH, Furnas BE, Powell N: Combination chemotherapy of disseminated testicular carcinoma with cis-platinum diammine chloride (CPDD), vinblastine (VLB), and bleomycin (BLEO). (Abstract.) Proc Am Assoc Cancer Res 1976; 17:240
Friedman M, Purkayastha MC: Recurrent seminoma: The management of late metastasis, recurrence, or a second primary tumor. Am J Roentgenol 1960; 83:25
Golbey RB, Reynolds TF, Vugrin D: The chemotherapy of metastatic germ cell tumors. Semin Oncol 1979; 6:82
Javadpour N: The value of biologic markers in the diagnosis and treatment of testicular carcinoma. Semin Oncol 1979; 6:37
Li MC et al: Effects of combined drug therapy on metastatic cancer of the testis. JAMA 1960; 174:1291
Samuels ML: Continuous intravenous bleomycin therapy with vinblastine in testicular and extragonadal germinal tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:112
Williams SD, Einhorn LH: Etoposide salvage therapy for refractory germ cell tumors: An update. Cancer Treat Rev 1982; 9 (Suppl A):67
Schmerztherapie bei Krebs
Brechner VL, Ferrer-Brechner T, Allen GD: Anaesthetic measures in management of pain associated with malignancy. Semin Oncol 1977; 4:99
Catalano RB: The medical approach to management of pain caused by cancer. Semin Oncol 1975; 2:379
Therapie des Erbrechens bei Chemotherapie
Frytak S, Moertel CG: Management of nausea and vomiting in the cancer patient. JAMA 1981; 245:393
Frytak S et al: Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A comparison with prochlorperazine and a placebo. Ann Intern Med 1979; 91:825
Gralla RJ et al: Antiemetic efficacy of high-dose meto-clopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305:905
Siegel LJ, Longo DL: The control of chemotherapy-induced emesis. Ann Intern Med 1981; 95:352
Bakterielle Sepsis bei Tumorpatienten
Alavi JB et al: Randomized clinical trial of granulocyte transfusions and infection in acute leukemia. N Engl J Med 1977; 296:706
Dilworth JA, Mandell GL: Infections in patients with cancer. Semin Oncol 1975; 2:349
Herzig R et al: Successful granulocyte transfusion therapy for gram-negative septicemia: A prospectively randomized controlled study. N Engl J Med 1977; 296:701
Ketchel SJ, Rodriguez V: Acute infections in cancer patients. Semin Oncol 1978; 5:167
Wiernik PH: The management of infection in the cancer patient. JAMA 1980; 244:185
Behandlung von Extravasaten durch Vesikanzien
Blacklock HA et al: Use of modified subcutaneous right-atrial catheter for venous access in leukaemic patients. Lancet 1980; 1:993
Larson DL: Treatment of tissue extravasation by antitumor agents. Cancer 1982; 49:1796
Behandlung, lokaler Tumorkomplikationen
Davenport D et al: Radiation therapy in the treatment of superior vena caval obstruction. Cancer 1978; 42:2600
Lambert CJ: Treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg 1967; 3:1
Lenhard RE Jr (editor): Clinical case records in chemotherapy: The management of hypercalcemia complicating cancer. Cancer Chemother Rep 1971; 55:509
Levitt SH et al: Treatment of malignant superior vena caval obstruction. Cancer 1969; 24:447
Millburn L, Hibbs GG, Hendrickson FR: Treatment of spinal cord compression from metastatic carcinoma. Cancer 1968; 21:447
Perez CA, Bradfield JS, Morgan HC: Management of pathologic fractures. Cancer 1972; 29:684
Rubin P et al: Superior vena caval syndrome: Slow low dose versus rapid high dose schedule. Radiology 1963; 81:388
Ernährungsbehandlung von Tumorpatienten
Copeland EM, Dudrick SJ: Cancer: Nutritional concepts. Semin Oncol 1975; 2:329
DeWys WD: Nutritional care of the cancer patient. JAMA 1980; 244:374
Psychologische Betreuung von Tumorpatienten
Dunphy JE: Caring for the patient with cancer. N Engl J Med 1976; 295:313
Häusliche Betreuung von Patienten mit fortgeschrittener Krebserkrankung
Rosenbaum EH: Principles of home care for the patient with advanced cancer. JAMA 1980; 244:1484
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Johnson, D.E., Swanson, D.A., von Eschenbach, A.C. (1992). Tumoren des Urogenitaltraktes. In: Tanagho, E.A., McAninch, J.W. (eds) Smiths Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76107-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-76107-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76108-9
Online ISBN: 978-3-642-76107-2
eBook Packages: Springer Book Archive